Southpoint Capital Advisors LP 10x Genomics, Inc. Transaction History
Southpoint Capital Advisors LP
- $3.43 Billion
- Q2 2024
A detailed history of Southpoint Capital Advisors LP transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Southpoint Capital Advisors LP holds 400,000 shares of TXG stock, worth $6.34 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
400,000
Previous 700,000
42.86%
Holding current value
$6.34 Million
Previous $26.3 Million
70.39%
% of portfolio
0.23%
Previous 0.59%
Shares
3 transactions
Others Institutions Holding TXG
# of Institutions
286Shares Held
95.8MCall Options Held
162KPut Options Held
107K-
Vanguard Group Inc Valley Forge, PA10.2MShares$162 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.31MShares$148 Million1.65% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$101 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.15MShares$97.5 Million1.4% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.14MShares$97.4 Million0.09% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.51B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...